MINNEAPOLIS--(BUSINESS WIRE)--Offering hope to millions of chronic pain sufferers around the world, a major study published online today by the international medical journal PAIN and supported by Medtronic, Inc. (NYSE:MDT) found that people with chronic neuropathic leg and back pain benefited significantly more from neurostimulation therapy plus conventional medical management than from conventional medical management alone.
